XML 160 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities      
Loss for the year $ (7,312,260) $ (51,788,880) $ (4,526,905)
Adjustments to reconcile loss for the year to net cash flows      
Income tax benefit (1,046,985) (234,542)
Amortization of intangible assets 713,374 94,517
Depreciation of fixed assets 177,155 27,505 1,699
Depreciation of right-of-use assets 123,632
Employee share-based payment 2,047,090 1,095,114 838,576
Change in fair value of Simply Agreement for Future Equity (“SAFE”) 313,346 860,000
Share based payment cost of listing shares (non-cash item) 42,705,061
Financial income / (expenses) (983,959) (1,452,876) 14,472
Changes in working capital      
Accounts receivable (94,474) (44,126)
Other receivables 367,560 (276,292)
Prepayments (291,846) (339,046) (1,703)
Inventories (5,793,226) 66,484
Accounts payable 2,502,486 1,485,151 926,711
Other liabilities 263,185 837,231 1,171
Net cash used in operating activities (9,328,268) (7,511,353) (1,885,979)
Cash flows from investing activities      
Acquisition of fixed assets (158,283) (14,824)
Cash paid for acquisition of ValoraSoy net of the cash acquired (1,930,883)
Acquisition of intangible assets (164,362)
Short term investment subscriptions (144,514) (2,572,783)
Short-term investments withdrawals 437,662 2,346,032
Net cash generated from / (used in) investing activities 134,865 (2,336,820)
Cash flows from financing activities      
Proceeds from issuance of share capital to UGVL and Theo (Backstop) 8,011,040
Proceeds from issuance of share capital to SPAC public holders (Trust) 1,988,975
Proceeds from issuance of convertible notes 10,940,000
Proceeds from financial debts 2,591,780 2,171,830
Payment of loans (2,512,486) (876,769)
Payments of interest (570,224) (24,098)
Proceeds from the SAFE 2,000,000
Proceeds from issue of shares 2,172,400 10,683
Payments of lease liabilities (105,120)
Deferred payment for acquisition of ValoraSoy (500,000)
Settlement with shareholders (addition of treasury shares) (see note 15) (305,000)
Net cash generated from financing activities 11,711,350 11,281,661 2,000,000
Net increase in cash and cash equivalents 2,517,947 1,433,488 114,021
Cash and cash equivalents at beginning of the year 2,527,673 1,081,808 980,527
Effect of exchange rate changes and inflation on cash and equivalents 344,308 12,377 (12,740)
Cash and cash equivalents at end of the year 5,389,928 2,527,673 1,081,808
Non-cash financing activities      
Issue of share capital and Share premium of New Shareholders through other non-current receivables 8,120,000
Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium 3,173,346
Capitalization of transaction expenses through Accounts payables 1,057,833
Net liabilities acquired through issuance of share capital 3,991,935
Acquisition of Business Combination trough deferred payment 488,430
Acquisition of Business Combination trough deferred payment in kind 217,916
Increase in Right-of-use asset recognition through an increase in Lease liabilities (521,107)
Increase in Intangible asset recognition through Accounts payables $ (1,000,000)